The results reflect well-established features of aggressive growth, such as increased cell proliferation, but also highlight less well-characterized aspects of tumor biology including alterations in cellular metabolism involving phosphoglycerate kinase 1, changes in transmembrane ion transport, and differences in the abundance of border-associated macrophages, which represent key distinctions between benign and aggressive meningiomas. The gene discussed is PGK1; the disease is meningioma.